Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (5,024,264)	$ (6,786,037)
Depreciation expense	10,155	10,139
Amortization of intangibles	39,643	39,982
Stock based compensation	1,113,427	1,097,838
Inventory Reserve	109,159	430,245
Employees paid in stock	317,500	217,262
Expense paid in stock	579,928	436,434
Unrealized gain on marketable securities	6,208	0
Bad debt expense	16,076	100,000
Amortization of right-of-use asset	69,067	59,698
Changes in operating assets and liabilities:
Decrease (increase) in accounts receivable	86,629	(248,457)
Increase in inventories	(799,454)	(440,574)
Increase in advances on contracts	(373,852)	(272,223)
Increase in prepaid expenses and other current assets	(134,881)	(102,858)
Increase in accounts payable	46,538	502,292
(Decrease) increase in accounts payable, related party	(166,855)	515,142
Decrease in accrued expenses	(13,098)	(367,074)
Increase (decrease) in accrued expenses, related party	103,287	(80,758)
Decrease operating right of use lease asset	(65,543)	(53,411)
Net cash used in operating activities	(4,080,330)	(4,942,360)
Cash flows from investing activities:
Purchase of furniture, fixtures, and equipment	(1,192)	(3,827)
Sale of Marketable securities	4,472,540	0
Purchase of Marketable securities	(6,929,218)	0
Net cash used in investing activities	(2,457,870)	(3,827)
Cash flows from financing activities:
Payments finance lease obligations	(6,486)	(6,486)
Net cash used in financing activities	(6,486)	(6,486)
Net decrease in cash and cash equivalents	(6,544,686)	(4,952,673)
Cash and cash equivalents at beginning of period	8,715,279	14,764,346
Cash and cash equivalents at end of period	$ 2,170,593	$ 9,811,673